JP3987878B1 - Method for producing ZnO antibacterial agent - Google Patents

Method for producing ZnO antibacterial agent Download PDF

Info

Publication number
JP3987878B1
JP3987878B1 JP2007010176A JP2007010176A JP3987878B1 JP 3987878 B1 JP3987878 B1 JP 3987878B1 JP 2007010176 A JP2007010176 A JP 2007010176A JP 2007010176 A JP2007010176 A JP 2007010176A JP 3987878 B1 JP3987878 B1 JP 3987878B1
Authority
JP
Japan
Prior art keywords
zno
antibacterial agent
aqueous solution
producing
solution containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2007010176A
Other languages
Japanese (ja)
Other versions
JP2008174498A (en
Inventor
健 廣田
秀樹 永井
亘 杉本
Original Assignee
健 廣田
株式会社メイスイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 健 廣田, 株式会社メイスイ filed Critical 健 廣田
Priority to JP2007010176A priority Critical patent/JP3987878B1/en
Application granted granted Critical
Publication of JP3987878B1 publication Critical patent/JP3987878B1/en
Publication of JP2008174498A publication Critical patent/JP2008174498A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Inorganic Compounds Of Heavy Metals (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Oxide Ceramics (AREA)

Abstract

【課題】暗所においても優れた抗菌性能を有するZnO系抗菌剤の製造方法を提供する。
【解決手段】この発明のZnO系抗菌剤の製造方法は、ZnO及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理する工程を含むことを特徴とする。また、この発明の別のZnO系抗菌剤の製造方法は、ZnO粉末を所定形状に成形して成形体を得る工程と、前記成形体を、亜鉛イオンを含有した水溶液に浸漬した状態でオートクレーブ中において水熱処理する工程と、前記水熱処理を経た成形体を焼結処理することによってZnO系多孔質焼結体を得る工程と、を含むことを特徴とする。
【選択図】なし
A method for producing a ZnO-based antibacterial agent having excellent antibacterial performance even in a dark place is provided.
A method for producing a ZnO antibacterial agent according to the present invention includes a step of hydrothermally treating an aqueous solution containing ZnO and zinc ions in an autoclave. Further, another method for producing a ZnO-based antibacterial agent according to the present invention includes a step of forming a ZnO powder into a predetermined shape to obtain a molded body, and an autoclave in which the molded body is immersed in an aqueous solution containing zinc ions. And a step of obtaining a ZnO-based porous sintered body by sintering the formed body that has undergone the hydrothermal treatment.
[Selection figure] None

Description

この発明は、暗所においても優れた抗菌性能を有するZnO系抗菌剤の製造方法に関する。   The present invention relates to a method for producing a ZnO-based antibacterial agent having excellent antibacterial performance even in a dark place.

ZnOは、光触媒作用によって抗菌性を示すことが知られており、例えばこのZnOの粉末を含有した分散液を、金属物品、ガラス物品等の物品の表面に塗布して表面コート層を形成することによって、物品に抗菌性能を付与できることが知られている(特許文献1参照)。
特開2000−37446号公報(請求項1〜3、段落0046、0047、0048)
ZnO is known to exhibit antibacterial properties by photocatalytic action. For example, a dispersion containing this ZnO powder is applied to the surface of an article such as a metal article or a glass article to form a surface coat layer. It is known that antibacterial performance can be imparted to an article (see Patent Document 1).
JP 2000-37446 A (Claims 1-3, paragraphs 0046, 0047, 0048)

しかしながら、上記従来技術では、抗菌性能を発揮させるためにはZnOに光が照射されていることが必要であり、暗所においては抗菌性能が殆ど得られないか又は全く得られないという問題があった。例えば、水の浄化装置内にこのようなZnOを配置せしめることで微生物の繁殖を抑制又は防止しようとしても、浄化装置内には光が入ってこないためにこのZnOにより抗菌を行うことはできなかった。   However, the above prior art requires that ZnO be irradiated with light in order to exhibit antibacterial performance, and there is a problem that little or no antibacterial performance is obtained in the dark. It was. For example, even if an attempt is made to suppress or prevent the growth of microorganisms by arranging such ZnO in a water purification device, no light enters the purification device, so that antibacterial activity cannot be performed with this ZnO. It was.

この発明は、かかる技術的背景に鑑みてなされたものであって、暗所においても優れた抗菌性能を有するZnO系抗菌剤の製造方法を提供することを目的とする。   This invention is made | formed in view of this technical background, Comprising: It aims at providing the manufacturing method of the ZnO type | system | group antibacterial agent which has the outstanding antibacterial performance also in the dark place.

前記目的を達成するために、本発明は以下の手段を提供する。   In order to achieve the above object, the present invention provides the following means.

[1]ZnO及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理する工程を含むことを特徴とするZnO系抗菌剤の製造方法。   [1] A method for producing a ZnO antibacterial agent, comprising a step of hydrothermally treating an aqueous solution containing ZnO and zinc ions in an autoclave.

[2]ZnO粉末及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理する工程と、
前記水熱処理を経たZnO粉末を所定形状に成形して成形体を得る工程と、
前記成形体を焼結処理することによってZnO系多孔質焼結体を得る工程と、を含むことを特徴とするZnO系抗菌剤の製造方法。
[2] a step of hydrothermally treating an aqueous solution containing ZnO powder and zinc ions in an autoclave;
A step of obtaining a molded body by molding the hydrothermally treated ZnO powder into a predetermined shape;
And a step of obtaining a ZnO-based porous sintered body by subjecting the molded body to a sintering treatment, and a method for producing a ZnO-based antibacterial agent.

[3]ZnO粉末を所定形状に成形して成形体を得る工程と、
前記成形体を、亜鉛イオンを含有した水溶液に浸漬した状態でオートクレーブ中において水熱処理する工程と、
前記水熱処理を経た成形体を焼結処理することによってZnO系多孔質焼結体を得る工程と、を含むことを特徴とするZnO系抗菌剤の製造方法。
[3] A step of forming a ZnO powder into a predetermined shape to obtain a molded body;
Hydrothermally treating the molded body in an autoclave while being immersed in an aqueous solution containing zinc ions;
And a step of obtaining a ZnO-based porous sintered body by sintering the molded body that has undergone the hydrothermal treatment.

[4]前記焼結処理を400〜600℃で1〜10時間行うことを特徴とする前項2または3に記載のZnO系抗菌剤の製造方法。   [4] The method for producing a ZnO-based antibacterial agent according to item 2 or 3, wherein the sintering treatment is performed at 400 to 600 ° C. for 1 to 10 hours.

[5]前記オートクレーブ中での水熱処理を1.2〜10気圧、110〜180℃の処理条件で行う前項1〜4のいずれか1項に記載のZnO系抗菌剤の製造方法。   [5] The method for producing a ZnO-based antibacterial agent according to any one of items 1 to 4, wherein the hydrothermal treatment in the autoclave is performed under a treatment condition of 1.2 to 10 atm and 110 to 180 ° C.

[6]前記亜鉛イオンを含有した水溶液として、硝酸亜鉛を含有した水溶液を用いる前項1〜5のいずれか1項に記載のZnO系抗菌剤の製造方法。   [6] The method for producing a ZnO-based antibacterial agent according to any one of items 1 to 5, wherein an aqueous solution containing zinc nitrate is used as the aqueous solution containing zinc ions.

[7]前記水溶液中における硝酸亜鉛の濃度が0.5〜5モル/Lである前項6に記載のZnO系抗菌剤の製造方法。   [7] The method for producing a ZnO-based antibacterial agent according to item 6 above, wherein the concentration of zinc nitrate in the aqueous solution is 0.5 to 5 mol / L.

[8]前記ZnO粉末として粒径が0.01〜0.30μmであるものを用いる前項1〜7のいずれか1項に記載のZnO系抗菌剤の製造方法。   [8] The method for producing a ZnO-based antibacterial agent according to any one of items 1 to 7, wherein the ZnO powder has a particle size of 0.01 to 0.30 μm.

[1]の発明では、ZnO及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理するので、得られたZnO系抗菌剤は、暗所においても優れた抗菌性能を有したものとなる。なお、得られたZnO系抗菌剤では、光が当たる条件下ではさらに優れた抗菌性能が発揮され得る。   In the invention of [1], since an aqueous solution containing ZnO and zinc ions is hydrothermally treated in an autoclave, the obtained ZnO antibacterial agent has excellent antibacterial performance even in a dark place. In addition, in the obtained ZnO type | system | group antibacterial agent, the further outstanding antibacterial performance may be exhibited on the conditions which light strikes.

[2]の発明では、ZnO粉末及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理した後、ZnO粉末を所定形状に成形して得た成形体を焼結処理するので、暗所においても優れた抗菌性能を有したZnO系多孔質焼結体を製造することができる。なお、得られたZnO系多孔質焼結体は、光が当たる条件下ではより優れた抗菌性能を発揮する。   In the invention of [2], an aqueous solution containing ZnO powder and zinc ions is hydrothermally treated in an autoclave, and then the molded product obtained by molding the ZnO powder into a predetermined shape is sintered, so that it is excellent even in the dark. A ZnO-based porous sintered body having antibacterial performance can be produced. In addition, the obtained ZnO type porous sintered body exhibits more excellent antibacterial performance under the condition of being exposed to light.

[3]の発明では、ZnO成形体を、亜鉛イオンを含有した水溶液に浸漬した状態でオートクレーブ中において水熱処理した後、焼結処理を行うので、暗所においても優れた抗菌性能を有したZnO系多孔質焼結体を製造することができる。本製造方法では、ZnOをオートクレーブ中で水熱処理する際にはZnOは既に所定形状に成形されており、水熱処理時のハンドリング性に優れていると共に、ZnO粉末を所定形状に成形することで水熱処理時のZnOの処理量を増大でき処理効率を向上させることができるから、生産効率を顕著に向上できる利点がある。この点において、この[3]の発明の製造方法は、前記[2]の発明の製造方法よりも好適である。なお、得られたZnO系多孔質焼結体は、光が当たる条件下ではより優れた抗菌性能を発揮する。   In the invention of [3], since the ZnO molded body is hydrothermally treated in an autoclave in a state of being immersed in an aqueous solution containing zinc ions, and then subjected to a sintering treatment, ZnO having excellent antibacterial performance even in a dark place A porous sintered body can be produced. In this production method, when hydrothermally treating ZnO in an autoclave, the ZnO is already formed into a predetermined shape, which is excellent in handling properties during hydrothermal treatment and is formed by forming ZnO powder into a predetermined shape. Since the throughput of ZnO during the heat treatment can be increased and the processing efficiency can be improved, there is an advantage that the production efficiency can be remarkably improved. In this respect, the manufacturing method of the invention of [3] is more preferable than the manufacturing method of the invention of [2]. In addition, the obtained ZnO type porous sintered body exhibits more excellent antibacterial performance under the condition of being exposed to light.

[4]の発明では、焼結処理を400〜600℃で1〜10時間行うから、より優れた抗菌性能を確保しつつ、多孔質焼結体として十分な強度を確保できる。   In the invention of [4], since the sintering treatment is performed at 400 to 600 ° C. for 1 to 10 hours, sufficient strength as a porous sintered body can be ensured while ensuring superior antibacterial performance.

[5]の発明では、オートクレーブ中での水熱処理を1.2〜10気圧、110〜180℃の処理条件で行うので、変質を生じさせることなく、十分な水熱処理を行うことができる。   In the invention of [5], since the hydrothermal treatment in the autoclave is performed under the treatment conditions of 1.2 to 10 atm and 110 to 180 ° C., sufficient hydrothermal treatment can be performed without causing alteration.

[6]の発明では、亜鉛イオンを含有した水溶液として、硝酸亜鉛を含有した水溶液を用いるので、暗所における抗菌性能をさらに向上させたものを製造できると共に、水中等で繰り返し使用しても抗菌性能が低下しない耐久性に優れた抗菌剤を製造できる。   In the invention of [6], since an aqueous solution containing zinc nitrate is used as an aqueous solution containing zinc ions, an antibacterial performance further improved in a dark place can be produced, and even if it is repeatedly used in water, the antibacterial property can be obtained. An antibacterial agent excellent in durability that does not deteriorate in performance can be produced.

[7]の発明では、水溶液中における硝酸亜鉛の濃度が0.5〜5モル/Lであるから、より一層暗所での抗菌性能に優れたZnO系抗菌剤を製造できる。   In the invention of [7], since the concentration of zinc nitrate in the aqueous solution is 0.5 to 5 mol / L, a ZnO-based antibacterial agent having further excellent antibacterial performance in a dark place can be produced.

[8]の発明では、原料として用いるZnO粉末の粒径が0.01〜0.30μmであるから、暗所における抗菌性能を十分に有したZnO系抗菌剤を製造できる。   In the invention of [8], since the particle diameter of the ZnO powder used as a raw material is 0.01 to 0.30 μm, a ZnO antibacterial agent having sufficient antibacterial performance in a dark place can be produced.

この発明に係るZnO系抗菌剤の製造方法は、ZnO(粉末、成形体等)及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理する工程を含むことを特徴とする。このように、ZnO(粉末、成形体等)を、亜鉛イオンを含有した水溶液中でオートクレーブにより水熱処理することによって得られたZnO系抗菌剤は、暗所においても優れた抗菌性能を有している。勿論、このZnO系抗菌剤は、光が当たる条件下では、より優れた抗菌性能が発揮されるものとなる。   The method for producing a ZnO-based antibacterial agent according to the present invention includes a step of hydrothermally treating an aqueous solution containing ZnO (powder, molded body, etc.) and zinc ions in an autoclave. Thus, the ZnO antibacterial agent obtained by hydrothermally treating ZnO (powder, molded body, etc.) with an autoclave in an aqueous solution containing zinc ions has excellent antibacterial performance even in the dark. Yes. Of course, this ZnO-based antibacterial agent exhibits more excellent antibacterial performance under the condition of being exposed to light.

ZnO系抗菌剤として所定形状に成形されたものを製造する場合には、次の第1製造方法または第2製造方法を採用するのが好ましい。   When manufacturing what was shape | molded by the predetermined shape as a ZnO type | system | group antibacterial agent, it is preferable to employ | adopt the following 1st manufacturing method or the 2nd manufacturing method.

[第1製造方法]
ZnO粉末及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理する工程と、前記水熱処理を経たZnO粉末を所定形状に成形して成形体を得る工程と、前記成形体を焼結処理することによってZnO系多孔質焼結体を得る工程と、を含むことを特徴とする。
[First production method]
By hydrothermally treating an aqueous solution containing ZnO powder and zinc ions in an autoclave, molding the ZnO powder subjected to the hydrothermal treatment into a predetermined shape to obtain a molded body, and sintering the molded body And a step of obtaining a ZnO-based porous sintered body.

[第2製造方法]
ZnO粉末を所定形状に成形して成形体を得る工程と、前記成形体を、亜鉛イオンを含有した水溶液に浸漬した状態でオートクレーブ中において水熱処理する工程と、前記水熱処理を経た成形体を焼結処理することによってZnO系多孔質焼結体を得る工程と、を含むことを特徴とする。
[Second production method]
A step of forming a ZnO powder into a predetermined shape to obtain a molded body, a step of hydrothermally treating the molded body in an autoclave while being immersed in an aqueous solution containing zinc ions, and a step of firing the molded body that has undergone the hydrothermal treatment. And a step of obtaining a ZnO-based porous sintered body by performing a sintering process.

この発明において、前記ZnO粉末の粒径は0.01〜0.30μmであるのが好ましい。0.30μmを超えると、得られるZnO系抗菌剤の抗菌性能が十分に得られ難くなるので、好ましくない。   In the present invention, the ZnO powder preferably has a particle size of 0.01 to 0.30 μm. If it exceeds 0.30 μm, the antibacterial performance of the obtained ZnO-based antibacterial agent becomes difficult to obtain sufficiently, which is not preferable.

前記オートクレーブ中で水熱処理する時の圧力は1.2〜10気圧に設定するのが好ましい。1.2気圧以上に設定することで水熱処理を十分に行うことができると共に、10気圧以下に設定することで変質を防止することができる。   The pressure during hydrothermal treatment in the autoclave is preferably set to 1.2 to 10 atmospheres. Hydrothermal treatment can be sufficiently performed by setting the pressure to 1.2 atmospheres or more, and alteration can be prevented by setting the pressure to 10 atmospheres or less.

また、前記オートクレーブ中で水熱処理する時の温度は110〜180℃に設定するのが好ましい。110℃以上であることで水熱処理を十分に行うことができると共に、180℃以下に設定することで変質を防止することができる。中でも、前記オートクレーブ中で水熱処理する時の温度は115〜125℃に設定するのが特に好ましい。   Moreover, it is preferable to set the temperature at the time of hydrothermal treatment in the autoclave to 110 to 180 ° C. Hydrothermal treatment can be sufficiently performed when the temperature is 110 ° C. or higher, and alteration can be prevented by setting the temperature to 180 ° C. or lower. Especially, it is especially preferable to set the temperature at the time of hydrothermal treatment in the autoclave to 115 to 125 ° C.

また、前記オートクレーブ中での水熱処理の処理時間は3〜10時間に設定するのが好ましい。3時間以上であることで水熱処理を十分に行うことができると共に、10時間以下であることで暗所における抗菌性能をさらに向上させることができる。中でも、前記オートクレーブ中での水熱処理の処理時間は6〜8時間に設定するのが特に好ましい。   The treatment time for hydrothermal treatment in the autoclave is preferably set to 3 to 10 hours. When it is 3 hours or more, hydrothermal treatment can be sufficiently performed, and when it is 10 hours or less, the antibacterial performance in the dark can be further improved. Especially, it is especially preferable to set the processing time of the hydrothermal treatment in the autoclave to 6 to 8 hours.

前記亜鉛イオンを含有した水溶液としては、特に限定されるものではないが、例えば硝酸亜鉛を含有した水溶液、塩化亜鉛を含有した水溶液、酢酸亜鉛を含有した水溶液等が挙げられる。これらの中でも、硝酸亜鉛を含有した水溶液を用いるのが好ましく、この場合には暗所における抗菌性能がさらに向上したZnO系抗菌剤を製造できる。   The aqueous solution containing zinc ions is not particularly limited, and examples thereof include an aqueous solution containing zinc nitrate, an aqueous solution containing zinc chloride, and an aqueous solution containing zinc acetate. Among these, it is preferable to use an aqueous solution containing zinc nitrate. In this case, a ZnO antibacterial agent having further improved antibacterial performance in a dark place can be produced.

前記水溶液中における硝酸亜鉛の濃度は0.5〜5モル/Lに設定するのが好ましい。0.5モル/L以上であることで十分に優れた暗所での抗菌性能を付与できると共に、5モル/L以下であることでZnO表面の過度の変質を防止できる。中でも、前記水溶液中における硝酸亜鉛の濃度は2〜4モル/Lに設定するのが特に好ましい。   The concentration of zinc nitrate in the aqueous solution is preferably set to 0.5 to 5 mol / L. When it is 0.5 mol / L or more, sufficiently excellent antibacterial performance in a dark place can be imparted, and when it is 5 mol / L or less, excessive deterioration of the ZnO surface can be prevented. Among these, the concentration of zinc nitrate in the aqueous solution is particularly preferably set to 2 to 4 mol / L.

前記焼結処理に供する成形体としては、ハンドリングを行い得る程度の強度を少なくとも備えていれば良い。   The molded body to be subjected to the sintering process only needs to have at least a strength that allows handling.

前記焼結処理の処理温度は400〜600℃に設定するのが好ましい。400℃以上であることで成形体として十分な強度を確保できると共に、600℃以下であることで暗所における抗菌性能をさらに向上させることができる。中でも、前記焼結処理の処理温度は450〜550℃に設定するのが特に好ましい。   The processing temperature of the sintering process is preferably set to 400 to 600 ° C. When the temperature is 400 ° C. or higher, sufficient strength as a molded body can be secured, and when the temperature is 600 ° C. or lower, antibacterial performance in a dark place can be further improved. Especially, it is especially preferable to set the processing temperature of the sintering process to 450 to 550 ° C.

また、前記焼結処理の処理時間は1〜10時間に設定するのが好ましい。1時間以上であることで成形体として十分な強度を確保できると共に、10時間以下であることで暗所における抗菌性能をさらに向上させることができる。中でも、前記焼結処理の処理時間は3〜7時間に設定するのが特に好ましい。   The processing time for the sintering process is preferably set to 1 to 10 hours. When it is 1 hour or longer, sufficient strength as a molded article can be secured, and when it is 10 hours or shorter, antibacterial performance in a dark place can be further improved. Especially, it is especially preferable to set the processing time of the sintering process to 3 to 7 hours.

前記焼結処理は、1段階で行っても良いし、或いは2段階以上の複数段階で行っても良い。例えば、450℃×1時間、470℃×1時間、485℃×1時間、500℃×2時間の順で4段階(計5時間)で行っても良い。   The sintering process may be performed in one stage, or may be performed in two or more stages. For example, it may be performed in four steps (total 5 hours) in the order of 450 ° C. × 1 hour, 470 ° C. × 1 hour, 485 ° C. × 1 hour, and 500 ° C. × 2 hours.

次に、この発明の具体的実施例について説明するが、本発明はこれら実施例のものに特に限定されるものではない。   Next, specific examples of the present invention will be described, but the present invention is not particularly limited to these examples.

<実施例1>
粒径0.02μmのZnO粉末(堺化学工業株式会社製、「NANOFINE P−2」、純度98.5%、比表面積52.0g/m2)を98MPaで一軸加圧金型成形することによって円盤状の成形体(16mmφ×厚さ10mm)を得た。この成形体を、3モル/Lの硝酸亜鉛水溶液に浸漬し、この浸漬状態でオートクレーブ中において水熱処理した。前記オートクレーブでの水熱処理は、2気圧、120℃の処理条件で7時間行った。次いで、前記水熱処理を経た成形体を空気雰囲気下500℃で5時間焼結処理することによって、ZnO系多孔質焼結体を得た。
<Example 1>
By uniaxially press-molding a ZnO powder (manufactured by Sakai Chemical Industry Co., Ltd., “NANOFINE P-2”, purity 98.5%, specific surface area 52.0 g / m 2 ) at 98 MPa with a particle size of 0.02 μm A disk-shaped molded body (16 mmφ × 10 mm thickness) was obtained. This molded body was immersed in a 3 mol / L zinc nitrate aqueous solution and hydrothermally treated in an autoclave in this immersed state. The hydrothermal treatment in the autoclave was carried out for 7 hours under the treatment conditions of 2 atm and 120 ° C. Next, the compact subjected to the hydrothermal treatment was sintered at 500 ° C. for 5 hours in an air atmosphere to obtain a ZnO-based porous sintered body.

<実施例2>
水熱処理時間を10時間にした以外は、実施例1と同様にして、ZnO系多孔質焼結体を得た。
<Example 2>
A ZnO-based porous sintered body was obtained in the same manner as in Example 1 except that the hydrothermal treatment time was 10 hours.

<実施例3>
硝酸亜鉛水溶液として、濃度が1モル/Lのものを用いた以外は、実施例1と同様にして、ZnO系多孔質焼結体を得た。
<Example 3>
A ZnO-based porous sintered body was obtained in the same manner as in Example 1 except that a zinc nitrate aqueous solution having a concentration of 1 mol / L was used.

<実施例4>
3モル/Lの硝酸亜鉛水溶液に代えて1モル/Lの酢酸亜鉛水溶液を用い、水熱処理時間を10時間にした以外は、実施例1と同様にして、ZnO系多孔質焼結体を得た。
<Example 4>
A ZnO-based porous sintered body was obtained in the same manner as in Example 1 except that a 1 mol / L zinc acetate aqueous solution was used in place of the 3 mol / L zinc nitrate aqueous solution and the hydrothermal treatment time was 10 hours. It was.

<実施例5>
粒径0.02μmのZnO粉末に代えて、粒径0.10μmのZnO粉末を用いた以外は、実施例1と同様にして、ZnO系多孔質焼結体を得た。
<Example 5>
A ZnO-based porous sintered body was obtained in the same manner as in Example 1 except that a ZnO powder having a particle size of 0.10 μm was used instead of the ZnO powder having a particle size of 0.02 μm.

<比較例1>
3モル/Lの硝酸亜鉛水溶液に代えて、イオン交換水を用いて水熱処理を行った以外は、実施例1と同様にして、ZnO系多孔質焼結体を得た。
<Comparative Example 1>
A ZnO-based porous sintered body was obtained in the same manner as in Example 1 except that hydrothermal treatment was performed using ion-exchanged water instead of the 3 mol / L zinc nitrate aqueous solution.

上記のようにして得られたZnO系多孔質焼結体について下記評価法に基づいて抗菌性の評価を行った。評価結果を表1に示す。   The antibacterial property was evaluated based on the following evaluation method for the ZnO-based porous sintered body obtained as described above. The evaluation results are shown in Table 1.

Figure 0003987878
Figure 0003987878

<抗菌性評価法>
Na−Pバッファー液(組成:KH2PO41.36g、1N−NaOH7.9mL、H2O492mL)に、大腸菌が入った水溶液を添加して、菌数をコロニーカウント法により測定した後、ここに滅菌処理が施されたZnO系多孔質焼結体を入れ、暗室において36℃で24時間静置し、この24時間経過後の菌数(個/mL)をコロニーカウント法により測定した。
<Antimicrobial evaluation method>
An aqueous solution containing Escherichia coli was added to Na-P buffer solution (composition: KH 2 PO 4 1.36 g, 1N-NaOH 7.9 mL, H 2 O 492 mL), and the number of bacteria was measured by the colony count method. The sterilized ZnO-based porous sintered body was put in the plate, allowed to stand at 36 ° C. for 24 hours in a dark room, and the number of bacteria (cells / mL) after the lapse of 24 hours was measured by the colony count method.

表1から明らかなように、この発明の製造方法で製造された実施例1〜5のZnO系多孔質焼結体(ZnO系抗菌剤)では、暗所において36℃で24時間静置後、菌が確認されず、これら焼結体は、暗所においても抗菌性能に優れていた。   As is clear from Table 1, in the ZnO-based porous sintered bodies (ZnO-based antibacterial agents) of Examples 1 to 5 manufactured by the manufacturing method of the present invention, after standing at 36 ° C. for 24 hours in the dark, Bacteria were not confirmed, and these sintered bodies were excellent in antibacterial performance even in the dark.

これに対し、イオン交換水中で水熱処理した比較例1のZnO系多孔質焼結体では、暗所において36℃で24時間静置後、菌が非常に多く存在しており、暗所における抗菌性能は殆ど認められなかった。   In contrast, in the ZnO-based porous sintered body of Comparative Example 1 hydrothermally treated in ion-exchanged water, there were very many bacteria after standing at 36 ° C. for 24 hours in the dark, and antibacterial in the dark. Little performance was observed.

この発明の製造方法で得られたZnO系抗菌剤は、例えば水の浄化装置内に配置される抗菌剤や抗菌フィルター等として好適に用いられるが、特にこのような用途に限定されるものではない。   The ZnO-based antibacterial agent obtained by the production method of the present invention is suitably used as an antibacterial agent or an antibacterial filter disposed in, for example, a water purification device, but is not particularly limited to such applications .

Claims (8)

ZnO及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理する工程を含むことを特徴とするZnO系抗菌剤の製造方法。   A method for producing a ZnO-based antibacterial agent, comprising a step of hydrothermally treating an aqueous solution containing ZnO and zinc ions in an autoclave. ZnO粉末及び亜鉛イオンを含有した水溶液をオートクレーブ中で水熱処理する工程と、
前記水熱処理を経たZnO粉末を所定形状に成形して成形体を得る工程と、
前記成形体を焼結処理することによってZnO系多孔質焼結体を得る工程と、を含むことを特徴とするZnO系抗菌剤の製造方法。
Hydrothermally treating an aqueous solution containing ZnO powder and zinc ions in an autoclave;
A step of obtaining a molded body by molding the hydrothermally treated ZnO powder into a predetermined shape;
And a step of obtaining a ZnO-based porous sintered body by subjecting the molded body to a sintering treatment, and a method for producing a ZnO-based antibacterial agent.
ZnO粉末を所定形状に成形して成形体を得る工程と、
前記成形体を、亜鉛イオンを含有した水溶液に浸漬した状態でオートクレーブ中において水熱処理する工程と、
前記水熱処理を経た成形体を焼結処理することによってZnO系多孔質焼結体を得る工程と、を含むことを特徴とするZnO系抗菌剤の製造方法。
Forming a ZnO powder into a predetermined shape to obtain a molded body;
Hydrothermally treating the molded body in an autoclave while being immersed in an aqueous solution containing zinc ions;
And a step of obtaining a ZnO-based porous sintered body by sintering the molded body that has undergone the hydrothermal treatment.
前記焼結処理を400〜600℃で1〜10時間行うことを特徴とする請求項2または3に記載のZnO系抗菌剤の製造方法。   The method for producing a ZnO-based antibacterial agent according to claim 2 or 3, wherein the sintering treatment is performed at 400 to 600 ° C for 1 to 10 hours. 前記オートクレーブ中での水熱処理を1.2〜10気圧、110〜180℃の処理条件で行う請求項1〜4のいずれか1項に記載のZnO系抗菌剤の製造方法。   The manufacturing method of the ZnO type | system | group antibacterial agent of any one of Claims 1-4 which performs the hydrothermal treatment in the said autoclave on the processing conditions of 1.2-10 atmospheres and 110-180 degreeC. 前記亜鉛イオンを含有した水溶液として、硝酸亜鉛を含有した水溶液を用いる請求項1〜5のいずれか1項に記載のZnO系抗菌剤の製造方法。   The method for producing a ZnO-based antibacterial agent according to any one of claims 1 to 5, wherein an aqueous solution containing zinc nitrate is used as the aqueous solution containing zinc ions. 前記水溶液中における硝酸亜鉛の濃度が0.5〜5モル/Lである請求項6に記載のZnO系抗菌剤の製造方法。   The method for producing a ZnO-based antibacterial agent according to claim 6, wherein the concentration of zinc nitrate in the aqueous solution is 0.5 to 5 mol / L. 前記ZnO粉末として粒径が0.01〜0.30μmであるものを用いる請求項2〜7のいずれか1項に記載のZnO系抗菌剤の製造方法。   The method for producing a ZnO-based antibacterial agent according to any one of claims 2 to 7, wherein the ZnO powder has a particle size of 0.01 to 0.30 µm.
JP2007010176A 2007-01-19 2007-01-19 Method for producing ZnO antibacterial agent Active JP3987878B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007010176A JP3987878B1 (en) 2007-01-19 2007-01-19 Method for producing ZnO antibacterial agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007010176A JP3987878B1 (en) 2007-01-19 2007-01-19 Method for producing ZnO antibacterial agent

Publications (2)

Publication Number Publication Date
JP3987878B1 true JP3987878B1 (en) 2007-10-10
JP2008174498A JP2008174498A (en) 2008-07-31

Family

ID=38640060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007010176A Active JP3987878B1 (en) 2007-01-19 2007-01-19 Method for producing ZnO antibacterial agent

Country Status (1)

Country Link
JP (1) JP3987878B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010042953A (en) * 2008-08-12 2010-02-25 Takeshi Hirota METHOD FOR PRODUCING POROUS CERAMIC-ZnO-BASED ANTIBACTERIAL COMPOSITE BODY
CN115572413A (en) * 2021-07-06 2023-01-06 天津碧海蓝天水性高分子材料有限公司 Nano-boehmite zinc-loaded inorganic composite antibacterial agent and preparation method thereof
CN117819954A (en) * 2024-01-04 2024-04-05 廊坊瑞耀建筑装饰工程有限公司 High-performance antibacterial domestic ceramic and preparation method and application thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010042953A (en) * 2008-08-12 2010-02-25 Takeshi Hirota METHOD FOR PRODUCING POROUS CERAMIC-ZnO-BASED ANTIBACTERIAL COMPOSITE BODY
CN115572413A (en) * 2021-07-06 2023-01-06 天津碧海蓝天水性高分子材料有限公司 Nano-boehmite zinc-loaded inorganic composite antibacterial agent and preparation method thereof
CN117819954A (en) * 2024-01-04 2024-04-05 廊坊瑞耀建筑装饰工程有限公司 High-performance antibacterial domestic ceramic and preparation method and application thereof

Also Published As

Publication number Publication date
JP2008174498A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
CN109851396B (en) Antibacterial ceramic tile and preparation method thereof
CN1107732C (en) Alloy having antibacterial effect and sterilizing effect
JP2860951B2 (en) Antimicrobial polymer composition
US20080085326A1 (en) Antimicrobial material compositions enriched with different active oxygen species
CN109896839B (en) Antibacterial and mildewproof ceramic tile and preparation method thereof
CN101744002B (en) Silicon-zinc mesoporous material silver-carrying antibacterial agent and preparation method thereof
JP3987878B1 (en) Method for producing ZnO antibacterial agent
JP6164707B1 (en) Method for producing antibacterial zinc oxide powder
CN106563176A (en) Atomic layer deposition-based preparation method for zinc oxide/carbon nanotube nano-antibacterial coating
CN115959635A (en) Monoatomic transition metal doped carbon nitride quantum dot, and chemical cutting preparation method and application thereof in water phase
KR20180128248A (en) Block type antibacterial filter and method of manufacturing tongue type antibacterial balls
CN111838183A (en) Composite metal colloid inorganic antibacterial agent, preparation method thereof and inorganic artificial stone thereof
US7094374B2 (en) Method for manufacturing ceramic balls for water treatment
CN113402855B (en) Antibacterial suction nozzle, preparation method thereof and electronic atomization device with suction nozzle
CN113265169A (en) Antibacterial antiviral formaldehyde-removing antifouling agent and preparation method thereof, glazed tile and preparation method thereof
KR102061021B1 (en) Method of manufacturing antibacterial ceramic powder having controlled nonstoichiometry
JPH11236304A (en) Silver-based antimicrobial composition and its production
JP4950143B2 (en) Method for producing porous ceramic-ZnO antibacterial composite
KR20220125762A (en) Method for manufacturing photocatalyst-substrate composite and photocatalyst-substrate composite manufactured therefrom
KR102558224B1 (en) Manufacturing method of activated carbon with antibiosis using nanometallic powder
CN116983756A (en) Nonmetal static antibacterial/deodorizing/washable multifunctional air filter material and preparation method thereof
CN116751031B (en) Antibacterial daily ceramic cup and preparation method thereof
CN115646515A (en) F and Ti co-doped Ag with formaldehyde purification and antibiosis functions 2 WO 4 Material and use thereof
JP4048307B2 (en) Photoactive film carrier and method for producing the same
JP2000017356A (en) Copper alloy having photocatalystic function and its production

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070710

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070713

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 3987878

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100720

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100720

Year of fee payment: 3

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100720

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110720

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120720

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120720

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130720

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130720

Year of fee payment: 6

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130720

Year of fee payment: 6

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130720

Year of fee payment: 6

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130720

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250